The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging

Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807

(2018) David T. Chien et al.   JOURNAL OF ALZHEIMERS DISEASE

Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue

(2015) Marta Marquié et al.   ANNALS OF NEUROLOGY

Tau positron emission tomographic imaging in aging and early Alzheimer disease

(2015) Keith A. Johnson et al.   ANNALS OF NEUROLOGY

Tau imaging: early progress and future directions

(2015) Victor L Villemagne et al.   LANCET NEUROLOGY

Partial volume correction in quantitative amyloid imaging

(2015) Yi Su et al.   NEUROIMAGE

The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia

(2015) Brian A. Gordon et al.   NeuroImage-Clinical

Primary age-related tauopathy (PART): a common pathology associated with human aging

(2014) John F. Crary et al.   ACTA NEUROPATHOLOGICA

In vivo tau imaging: Obstacles and progress

(2014) Victor L. Villemagne et al.   Alzheimers & Dementia

Non-invasive assessment of Alzheimer’s disease neurofibrillary pathology using 18F-THK5105 PET

(2014) Nobuyuki Okamura et al.   BRAIN

In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease

(2014) Victor L. Villemagne et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Surface-based partial-volume correction for high-resolution PET

(2014) Thomas Funck et al.   NEUROIMAGE

Permutation inference for the general linear model

(2014) Anderson M. Winkler et al.   NEUROIMAGE

[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease

(2013) Chun-Fang Xia et al.   Alzheimers & Dementia

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

(2013) Clifford R Jack et al.   LANCET NEUROLOGY

Correction of partial volume effect in 18F-FDG PET brain studies using coregistered MR volumes: Voxel based analysis of tracer uptake in the white matter

(2013) Christopher Coello et al.   NEUROIMAGE

Quantitative Analysis of PiB-PET with FreeSurfer ROIs

(2013) Yi Su et al.   PLoS One

Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease

(2013) T. L. S. Benzinger et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Changes in Amyloid-  and Tau in the Cerebrospinal Fluid of Transgenic Mice Overexpressing Amyloid Precursor Protein

(2013) L. F. Maia et al.   Science Translational Medicine

Amyloid-beta plaque growth in cognitively normal adults: Longitudinal [11C]Pittsburgh compound B data

(2011) Andrei G. Vlassenko et al.   ANNALS OF NEUROLOGY

An MR image-guided, voxel-based partial volume correction method for PET images

(2011) Hesheng Wang et al.   MEDICAL PHYSICS

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY

Cerebrospinal fluid tau and ptau181increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease

(2009) Anne M. Fagan et al.   EMBO Molecular Medicine

A new voice for global neurology?

(2009) The Lancet Neurology   LANCET NEUROLOGY

The Brain's Default Network

(2008) Randy L. Buckner et al.   Annals of the New York Academy of Sciences

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

(2008) Milos D. Ikonomovic et al.   BRAIN

Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference

(2008) S SMITH et al.   NEUROIMAGE